Claritev Q3 revenue $246M (+6.7%), adj EBITDA $155.1M, raises FY guidance

Claritev Corp

2025-Q3 EPS reported -$12.42 revenue$718,859,000

Q3 revenue $246M (+6.7% YoY); net loss $69.8M vs $391.5M in Q3 2024.
Adjusted EBITDA $155.1M (+9.5% YoY), margin 63.1% vs 61.5%.
FY 2025 revenue growth guidance raised to 2.8%-3.2% from flat-to-2%.
Free cash flow -$16.3M vs +$41.1M; operating cash flow $19.9M vs $72.8M.
Processed $45.9B in claim charges; identified $6.1B potential medical savings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.